Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates `
2.2. Market Overview

3. Market Dynamics
3.1. Parent Market Analysis: Vaccine Market
3.2. Market Definition
3.3. Key Drivers
3.3.1. Government Immunization Programs To Eradicate Ailments From The Society
3.3.2. Rise In The Cases Of Influenza
3.3.3. Technology Advancement
3.4. Key Restraints
3.4.1. High Cost Of Development
3.4.2. Lengthy Process Of Development

4. Key Analytics
4.1. Key Investment Insights
4.2. Porter’S Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape

5. Market By Type
5.1. Quadrivalent Vaccine
5.2. Trivalent Vaccine

6. Market By Technology
6.1. Egg-Based Technology
6.2. Cell-Based Technology

7. Market By Age Group
7.1. Pediatric Age Group
7.2. Adult Age Group

8. Market By Delivery Mode
8.1. Injection
8.2. Nasal Spray

9. Geographical Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada

10. Company Profiles
10.1. Merck
10.2. Novartis Ag
10.3. Pfizer Inc
10.4. Sanofi
10.5. Biodiem
10.6. Emergent Biosolutions
10.7. F. Hoffmann-La Roche Ltd
10.8. Glaxosmithkline
10.9. Abbott
10.10. Csl Ltd



List of Figures


List of Figures


Figure 1: Key Investment Insights
Figure 2: Porter’S Five Force Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: North America Influenza Vaccine Market, Growth Potential, By Type, In 2019
Figure 6: North America Influenza Vaccine Market, By Quadrivalent Vaccine, 2020-2028 (In $ Million)
Figure 7: North America Influenza Vaccine Market, By Trivalent Vaccine, 2020-2028 (In $ Million)
Figure 8: North America Influenza Vaccine Market, Growth Potential, By Technology, In 2019
Figure 9: North America Influenza Vaccine Market, By Egg-Based Technology, 2020-2028 (In $ Million)
Figure 10: North America Influenza Vaccine Market, By Cell-Based Technology, 2020-2028 (In $ Million)
Figure 11: North America Influenza Vaccine Market, Growth Potential, By Age Group, In 2019
Figure 12: North America Influenza Vaccine Market, By Pediatric Age Group, 2020-2028 (In $ Million)
Figure 13: North America Influenza Vaccine Market, By Adult Age Group, 2020-2028 (In $ Million)
Figure 14: North America Influenza Vaccine Market, Growth Potential, By Delivery Mode, In 2019
Figure 15: North America Influenza Vaccine Market, By Injection, 2020-2028 (In $ Million)
Figure 16: North America Influenza Vaccine Market, By Nasal Spray, 2020-2028 (In $ Million)
Figure 17: North America Influenza Vaccine Market, Regional Outlook, 2019 & 2028 (In %)
Figure 18: United States Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 19: Canada Influenza Vaccine Market, 2020-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - INFLUENZA VACCINE
TABLE 2: NORTH AMERICA INFLUENZA VACCINE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: NORTH AMERICA INFLUENZA VACCINE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA INFLUENZA VACCINE MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: NORTH AMERICA INFLUENZA VACCINE MARKET, BY TECHNOLOGY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA INFLUENZA VACCINE MARKET, BY AGE GROUP, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: NORTH AMERICA INFLUENZA VACCINE MARKET, BY AGE GROUP, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA INFLUENZA VACCINE MARKET, BY DELIVERY MODE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: NORTH AMERICA INFLUENZA VACCINE MARKET, BY DELIVERY MODE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA INFLUENZA VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: NORTH AMERICA INFLUENZA VACCINE MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)